Search - tctmd.com

Displaying 1 - 20 of 92

Sort: Relevancy | Date

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

News Daily News

CAD Common in MitraClip Patients, but When and If to Fix Are Unclear

Shelley Wood

December 03, 2020

News Daily News

NT-proBNP Level Helps ID Patients Who Won't Benefit From TAVR

Todd Neale

November 30, 2020

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Shelley Wood

November 26, 2020

News Daily News

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

Michael O'Riordan

November 18, 2020

News Daily News

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Caitlin E. Cox

November 17, 2020

News Opinion CV Team Dispatch

November 2020 News Roundup

L.A. McKeown

November 01, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

News Daily News

As Cardiac Procedures Plummet, Concerns Mount for COVID-19’s Collateral Damage

Shelley Wood

October 22, 2020

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

News Conference News TCT 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Michael O'Riordan

October 16, 2020

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

Presenter: Philippe Genereux

October 16, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

Presentation TCT 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presenter: Corrado Tamburino

October 15, 2020

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

Presentation TCT 2020

TCT 603: How Low Can You Go? Severe Aortic Stenosis with a Short Left Coronary Ostial Height

Presenter: Adithya Mathews

October 14, 2020

Presentation TCT 2020

TCT 126: Outcomes of Patients With Severe Aortic Stenosis and Left Ventricular Obstruction Undergoing Transcatheter Aortic Valve Replacement

Presenter: Danon Kaewkes

October 14, 2020

Presentation TCT 2020

TCT 119: Outcomes of Transcatheter Aortic Valve Replacement in Patients With Mixed Aortic Valve Disease Versus Pure Aortic Stenosis

Presenter: Raviteja Guddeti

October 14, 2020

Advertisement

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Funding the Future: How Industry Support for CV Trials Could Evolve

CAD Common in MitraClip Patients, but When and If to Fix Are Unclear

NT-proBNP Level Helps ID Patients Who Won't Benefit From TAVR

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

November 2020 News Roundup

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

As Cardiac Procedures Plummet, Concerns Mount for COVID-19’s Collateral Damage

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

TCT 603: How Low Can You Go? Severe Aortic Stenosis with a Short Left Coronary Ostial Height

TCT 126: Outcomes of Patients With Severe Aortic Stenosis and Left Ventricular Obstruction Undergoing Transcatheter Aortic Valve Replacement

TCT 119: Outcomes of Transcatheter Aortic Valve Replacement in Patients With Mixed Aortic Valve Disease Versus Pure Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content